Areas of Research

There have been many potential areas for which psychedelics

may have some clinical utility.

 

PsiloTec will be exploring many of these, and determining which are

most likely to benefit from a combination of psilocybin and therapy.

 

We are planning to start in the following 6 main areas,

but we anticipate rapidly expanding beyond these.

 

Ongoing clinical research studies will help to identify the most

appropriate type of mushroom, dosing regime,

and psychological support to give

the best possible outcomes.

 

Our initial 6 areas of research are:

Clinical Trials may include disorders such as.... 

  • Social Anxiety

  • Generalized Anxiety

  • Anxiety including Panic Attack Disorder

  • Major Depressive Disorder

  • Mixed Anxiety and Depression

  • Mood and/or Emotional instability

Mood and Anxiety Disorders

Clinical Trials may include disorders such as.... 

  • Alcohol abuse or dependence

  • Opiate abuse or dependence

  • Cocaine abuse or dependence

  • Mixed Drug abuse or dependence

Addiction Disorders

Clinical Trials may include disorders such as.... 

  • Past Trauma (bullying, emotional, physical, work, etc.)

  • Family violence

  • Grieving / End-of-life related / Cancer diagnosis

  • Post-burn injury / Post-spinal-cord injury / Adult post-amputation

Trauma and/or loss related

Clinical Trials may include disorders such as.... 

  • Post-brain injury

  • Adult attention deficit disorder with or without hyperactivity (ADHD / ADD)

  • Adult autism

  • Post-stroke

  • Adult Fetal Alcohol Spectrum (FAS) Disorder

  • Cognitive deterioration / Early dementia / Alzheimer’s Disorder

  • Multiple Sclerosis

Neuropsychiatric

Clinical Trials may include disorders such as.... 

  • Chronic migraine / headaches

  • Chronic back pain / chronic arthritis / chronic pain from any other cause

Pain

Clinical Trials may include disorders such as.... 

  • Post-COVID-19 syndrome

  • Chronic Fatigue

  • Sleep Disorders

 Stress, Fatigue, and Sleep related

Scientist